GOLDMAN SACHS GROUP INC - CATABASIS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 63 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$170,000
+68.3%
80,717
+130.7%
0.00%–
Q1 2021$101,000
+197.1%
34,992
+118.7%
0.00%–
Q4 2020$34,000
-82.1%
15,998
-47.8%
0.00%–
Q3 2020$190,000
-29.6%
30,662
-27.1%
0.00%–
Q2 2020$270,000–42,043–0.00%–
 Download
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q1 2021.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders